Home NDC 50090-3254 acyclovir
Product NDC 50090-3254
11-digit product format 500903254
Labeler code 50090
Product ID 50090-3254_3f43e431-4717-4fa0-b40f-21348c560796
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acyclovir
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA204314
Marketing category ANDA
Marketing start 2014-09-10
Substance ACYCLOVIR
Active strength 400 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base acyclovir
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 400 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197311
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-3254-0 acyclovir 90 in 1 BOTTLE TABLET 90 8 50090-3254-1 acyclovir 21 in 1 BOTTLE TABLET 21 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-3254 ACYCLOVIR TABLET [A-S MEDICATION SOLUTIONS] 8 Current NDC, Legacy NDC, 2 package rows 20240127_f3e6b1ad-810b-4f53-b92a-b28fc2111f3f.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-3254-0 50090325400 90 TABLET in 1 BOTTLE (50090-3254-0) 90 tablet 2017-11-17 0000-00-00 No No Current 50090-3254-1 50090325401 21 TABLET in 1 BOTTLE (50090-3254-1) 21 tablet 2017-11-09 0000-00-00 No No Current